Spruce Biosciences, Inc. - Common Stock (NQ:SPRB)

45.71 +0.94 (+2.10%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Spruce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates

March 13, 2024

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH

March 13, 2024

From Spruce Biosciences, Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 13, 2024

Pre-market stock movers are a hot topic on Tuesday and we're diving into all of the biggest winners and losers this morning!

Via InvestorPlace

What 4 Analyst Ratings Have To Say About Spruce Biosciences ↗

November 20, 2023

Via Benzinga

Spruce Biosciences Inc. (NASDAQ: SPRB) Making Surprising Moves in Tuesday Session

September 12, 2023

Via Investor Brand Network

Analyst Ratings for Spruce Biosciences ↗

September 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 30, 2024

Via Benzinga

Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

January 30, 2024

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasia

January 22, 2024

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH

January 05, 2024

From Spruce Biosciences, Inc.

Via Business Wire

Expert Ratings for Spruce Biosciences ↗

August 16, 2023

Via Benzinga

Analyst Expectations for Spruce Biosciences's Future ↗

May 16, 2023

Via Benzinga

Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024

January 04, 2024

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

November 13, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences to Participate in the Jefferies London Healthcare Conference

November 02, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Top 4 Health Care Stocks That May Rocket Higher This Month ↗

October 20, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Spruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal Hyperplasia

October 18, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

September 08, 2023

Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 97.6% to $1.6608 after the company announced non-exclusive licensing agreement for CNSide with Plus Therapeutics.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023 ↗

September 08, 2023

Via Benzinga

Why Smith & Wesson Brands Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

September 08, 2023

Gainers Impel Pharmaceuticals Inc. (NASDAQ: IMPL) rose 41.3% to $0.54 in pre-market trading after falling 4% on Thursday.

Via Benzinga

Adobe To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Friday ↗

September 08, 2023

B of A Securities cut the price target for DigitalOcean Holdings, Inc. (NYSE: DOCN) from $47 to $25. B of A Securities analyst Wamsi Mohan downgraded the stock from Buy to Underperform. DigitalOcean...

Via Benzinga

Spruce Biosciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

August 28, 2023

From Spruce Biosciences

Via Business Wire

Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates

August 14, 2023

From Spruce Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 27, 2023

Via Benzinga

Spruce Biosciences Announces Acceptance of Abstract for Presentation at the Annual Meeting of the Endocrine Society (ENDO 2023)

June 12, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Appoints Percival Barretto-Ko to Board of Directors

May 25, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences to Participate in the Jefferies Healthcare Conference

May 24, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Honored at CARES Foundation 15th Annual Everyone CARES Gala

May 22, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates

May 15, 2023

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting

May 04, 2023

From Spruce Biosciences, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.